 |
49 Diseases |  |
11 Trials |
|
11 Trials |  |
798 News |  |
| «12...3456789101112131415 |
- nimodipine / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Effectiveness of Nimodipine Plus Antidepressant Medication in Treating Vascular Depression (clinicaltrials.gov) - Jun 27, 2014
P4, N=9, Completed, Sponsor: University of Pittsburgh
Recruiting --> Completed | N=30 --> 9 | Trial primary completion date: Aug 2010 --> Feb 2012
- | acetazolamide / Generic mfg., nimodipine / Generic mfg.
New P2 trial: Carbonic Anhydrase Antagonism in Subarachnoid Hemorrhage (clinicaltrials.gov) - Jun 18, 2014
P2, N=140, Not yet recruiting, Sponsor: University of Florida
- nimodipine / Generic mfg.
Enrollment closed: Nimodipine to Prevent LH Surge During Ovulation Induction: Blinded Placebo-controlled RCT (clinicaltrials.gov) - Mar 23, 2014
P=N/A, N=90, Active, not recruiting, Sponsor: Boston IVF
Recruiting --> Completed | N=30 --> 9 | Trial primary completion date: Aug 2010 --> Feb 2012 Recruiting --> Active, not recruiting
- |||| nimodipine microparticles (EG-1962) / PDS Biotech
Enrollment open: Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage (clinicaltrials.gov) - Sep 24, 2013
P1/2, N=96, Recruiting, Sponsor: Edge Therapeutics Inc
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- ||||| nimodipine microparticles (EG-1962) / PDS Biotech
New P1/2 trial: Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage (clinicaltrials.gov) - Jul 4, 2013
P1/2, N=96, Recruiting, Sponsor: Edge Therapeutics Inc
- nimodipine / Generic mfg.
New P1 trial: Dose Finding Study of Nimodipine for the Treatment of Progranulin Insufficiency From GRN Gene Mutations (clinicaltrials.gov) - Apr 17, 2013
P1, N=8, Recruiting, Sponsor: University of California, San Francisco
- nimodipine / Generic mfg.
Trial initiation date: Use of a Calcium Channel Blocker to Prevent Premature Luteinizing Hormone Surges in Infertility Patients (clinicaltrials.gov) - Apr 18, 2012
P2, N=90, Not yet recruiting, Sponsor: Mount Sinai Hospital, Canada
Not yet recruiting --> Recruiting Initiation date: Mar 2012 --> Jul 2012
- | nimodipine / Generic mfg.
New P2 trial: Use of a Calcium Channel Blocker to Prevent Premature Luteinizing Hormone Surges in Infertility Patients (clinicaltrials.gov) - Mar 8, 2012
P2, N=90, Not yet recruiting, Sponsor: Mount Sinai Hospital, Canada